SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-22-072312
Filing Date
2022-11-14
Accepted
2022-11-14 16:40:16
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea168523-defa14a_hoththerape.htm DEFA14A 10484
2 GRAPHIC image_001.jpg GRAPHIC 115223
3 GRAPHIC image_002.jpg GRAPHIC 135386
  Complete submission text file 0001213900-22-072312.txt   356748
Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020
Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261
Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)

IRS No.: 821553794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38803 | Film No.: 221386707
SIC: 2834 Pharmaceutical Preparations